Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 29:18:769-780.
doi: 10.3762/bjoc.18.77. eCollection 2022.

Synthesis of bis-spirocyclic derivatives of 3-azabicyclo[3.1.0]hexane via cyclopropene cycloadditions to the stable azomethine ylide derived from Ruhemann's purple

Affiliations

Synthesis of bis-spirocyclic derivatives of 3-azabicyclo[3.1.0]hexane via cyclopropene cycloadditions to the stable azomethine ylide derived from Ruhemann's purple

Alexander S Filatov et al. Beilstein J Org Chem. .

Abstract

A reliable method for the synthesis of bis-spirocyclic derivatives of 3-azabicyclo[3.1.0]hexanes through the 1,3-dipolar cycloaddition (1,3-DC) reactions of cyclopropenes to the stable azomethine ylide - protonated form of Ruhemann's purple (PRP) has been developed. Both 3-substituted and 3,3-disubstituted cyclopropenes reacted with PRP, affording the corresponding bis-spirocyclic 3-azabicyclo[3.1.0]hexane cycloadducts in moderate to good yields with high diastereofacial selectivity. Moreover, several unstable 1,2-disubstituted cyclopropenes were successfully trapped by the stable 1,3-dipole under mild conditions. The mechanism of the cycloaddition reactions of cyclopropenes with PRP has been thoroughly studied using density functional theory (DFT) methods at the M11/cc-pVDZ level of theory. The cycloaddition reactions have been found to be HOMOcyclopropene-LUMOylide controlled while the transition-state energies for the reaction of 3-methyl-3-phenylcyclopropene with PRP are fully consistent with the experimentally observed stereoselectivity.

Keywords: DFT calculations; azomethine ylides; cycloaddition; cyclopropenes; spiro heterocycles.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Early studies concerning cyclopropene cycloadditions to azomethine ylides and cycloaddition reactions involving protonated Ruhemann's purple (PRP).
Scheme 2
Scheme 2
The pilot experiment aimed at studying the cycloaddition reaction between the protonated form of Ruhemann's purple (1) and 1,2,3-triphenylcyclopropene (2a).
Scheme 3
Scheme 3
Synthesis of meso-3'-azadispiro[indene-2,2'-bicyclo[3.1.0]hexane-4',2''-indene] derivatives 3bg via 1,3-DC reactions of N-protonated Ruhemann's purple (1) with 3-substituted 1,2-diphenylcyclopropenes 2bg.
Figure 1
Figure 1
ORTEP representation of the molecular structure of 3e.
Scheme 4
Scheme 4
The reaction of protonated Ruhemann's purple (1) with 3-methyl-3-phenylcyclopropene (2j).
Scheme 5
Scheme 5
Attempts to carry out the cycloaddition reactions between 3,3-disubstituted cyclopropenes 2k,l and azomethine ylide 1.
Scheme 6
Scheme 6
The reactions of protonated Ruhemann's purple (1) with unstable cyclopropenes 2mp.
Scheme 7
Scheme 7
The acid–base reaction of Ruhemann's purple with hydrochloric acid and relative Gibbs free energy change (ΔG, kcal/mol) for acid–base reactions resulting in the formation of three protonated forms of Ruhemann's purple.
Scheme 8
Scheme 8
Plausible mechanism of the 1,3-DC reaction of protonated Ruhemann's purple (1) with 3-methyl-3-phenylcyclopropene (2j) and corresponding DFT calculations (relative Gibbs free energy change between reagents, transition states and possible products are given in kcal/mol).
Scheme 9
Scheme 9
Plausible mechanism of the 1,3-DC reaction of protonated Ruhemann's purple (1) with 1-chloro-2-phenylcyclopropene (2m) and corresponding DFT calculations (relative Gibbs free energy change between reagents, transition states and possible invertomers are given in kcal/mol).

Similar articles

Cited by

References

    1. Saraswat P, Jeyabalan G, Hassan M Z, Rahman M U, Nyola N K. Synth Commun. 2016;46:1643–1664. doi: 10.1080/00397911.2016.1211704. - DOI
    1. Khanna P, Panda S S, Khanna L, Jain S C. Mini-Rev Org Chem. 2014;11:73–86. doi: 10.2174/1570193x1101140402101831. - DOI
    1. Acosta-Quiroga K, Rojas-Peña C, Nerio L S, Gutiérrez M, Polo-Cuadrado E. RSC Adv. 2021;11:21926–21954. doi: 10.1039/d1ra01170g. - DOI - PMC - PubMed
    1. Ramdani L H, Talhi O, Taibi N, Delort L, Decombat C, Silva A, Bachari K, Vasson M P, Caldefie-Chezet F. Anticancer Res. 2016;36:6399–6408. doi: 10.21873/anticanres.11237. - DOI - PubMed
    1. Goyard D, Kónya B, Chajistamatiou A S, Chrysina E D, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, et al. Eur J Med Chem. 2016;108:444–454. doi: 10.1016/j.ejmech.2015.12.004. - DOI - PubMed

LinkOut - more resources